NCT00554268View on ClinicalTrials.gov

Trial of PBI-05204 in Advanced Cancer Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Solid Tumors
Interventions
DRUG

PBI-05204

Starting dose = 0.0083 mg/kg/day by mouth (PO) x 3 weeks per cycle

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00554268 - Trial of PBI-05204 in Advanced Cancer Patients | Biotech Hunter | Biotech Hunter